1. Berke, G. The function and mechanism of action of cytolytic lymphocytes. in Fundamental Immunology, 3rd edn. (ed. Paul, W.E.) 965–1014 1993.
2. Rosenberg, S. Adoptive immunotherapy for cancer. Sci. Am. 262(5), 62 69 1990
3. Parmiani, G. An explanation of the variable clinical response to interleukin 2 and LAK cells. Immunol. Today 11, 113–115 1990).
4. Sasaki, A., Melder, R.J., Whiteside, T.L., Herberman, R.B., Jain, R.K. Preferential localization of human adherent lymphokineactivated killer cells in tumor microcirculation. j.Natl. CancerInst. 83, 433–437 1991.
5. Melder, R.J., Brownell, A.L., Shoup, T.M., Brownell, G.L., Jain, R.K. Imaging of activatednatural killer cells in mice by positron emissiontomography: Preferential up take in tumors. Cancer Res. 53, 5876–5881 1993.